To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer
Clinical trial NCT03676192 · COMPLETED
Trial details
- NCT number
- NCT03676192
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2021-04-22
- Enrollment
- 689
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.